marketcap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings ROA Ratio 2011-2025 | MEDP
Annual ROA Ratio Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.25 | 17.07 | 18.14 | 10.96 | 10.45 | 8.79 | 7.56 | 4.11 | 1.37 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.25 | 1.37 | 10.86 |
Quarterly ROA Ratio Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.75 | 21.04 | 19.89 | 14.94 | 19.69 | 19.81 | 19.54 | 14.31 | 19.28 | 19.5 | 19.72 | 14.09 | 17.17 | 10.72 | 13.44 | 8.78 | 11.76 | 11.66 | 10.68 | 6.8 | 9.4 | 8.52 | 9.19 | 8.79 | 8.53 | 8.43 | 7.74 | 7.56 | 6.4 | 5.44 | 4.73 | 4.11 | 2.93 | 2.41 | 1.91 | 1.37 | 0.5 | -0.03 | -0.53 | -0.89 | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.75 | -0.89 | 10.05 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | $ 0.33 | -6.23 % | $ 30.6 M |  Germany |
 |
Fluidigm Corporation
FLDM
|
-16.33 | $ 3.75 | 1.08 % | $ 308 M |  USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | $ 2.99 | - | $ 399 M |  China |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | $ 21.99 | - | $ 562 M |  Britain |
 |
Genetron Holdings Limited
GTH
|
-33.12 | $ 4.03 | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
-37.2 | $ 0.46 | 0.22 % | $ 16.8 M | USA |
 |
Meridian Bioscience
VIVO
|
9.17 | $ 33.97 | - | $ 1.49 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | $ 0.48 | -20.0 % | $ 1.06 M | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 5.92 | -4.67 % | $ 1.28 B | USA |
 |
Quotient Limited
QTNT
|
-50.51 | $ 0.32 | -11.32 % | $ 1.1 M |  Schweiz |
 |
Pacific Biosciences of California
PACB
|
-17.57 | $ 1.85 | -3.4 % | $ 469 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 7.42 | 0.54 % | $ 465 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | $ 165.21 | - | $ 10.7 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | $ 119.99 | - | $ 1.31 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | $ 0.17 | -34.28 % | $ 263 K |  Israel |
 |
Biocept
BIOC
|
-103.93 | $ 0.43 | -13.05 % | $ 7.29 M | USA |
 |
Thermo Fisher Scientific
TMO
|
6.51 | $ 565.62 | -0.38 % | $ 216 B | USA |
 |
Syneos Health
SYNH
|
2.85 | $ 42.98 | - | $ 4.46 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.78 | $ 1.0 | 0.49 % | $ 61.9 M |  Irlanda |
 |
Invitae Corporation
NVTA
|
-5.11 | $ 0.09 | - | $ 21.2 M | USA |
 |
DermTech
DMTK
|
-82.74 | $ 0.09 | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
-8.88 | $ 0.29 | -17.87 % | $ 25.9 M |  Canada |
 |
Twist Bioscience Corporation
TWST
|
-33.98 | $ 30.2 | -4.19 % | $ 1.75 B | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 33.8 | 0.69 % | $ 939 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 12.58 | -7.4 % | $ 357 M | Israel |
 |
PerkinElmer
PKI
|
2.18 | $ 115.24 | -0.91 % | $ 14.7 B | USA |
 |
OpGen
OPGN
|
121.6 | $ 1.96 | -16.95 % | $ 1.54 M | USA |
 |
DexCom
DXCM
|
8.64 | $ 57.98 | -2.19 % | $ 22.4 B | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | $ 2.12 | -2.3 % | $ 19.4 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 12.38 | 1.43 % | $ 132 M | China |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 28.25 | 0.61 % | $ 20 B |  Niderland |
 |
Danaher Corporation
DHR
|
5.03 | $ 211.09 | -0.57 % | $ 154 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.55 | -1.16 % | $ 5.86 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 22.3 | -2.11 % | $ 674 M | USA |
 |
Psychemedics Corporation
PMD
|
-33.7 | $ 2.67 | -1.84 % | $ 15.3 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | $ 0.77 | - | $ 7.1 B |  Australia |
 |
Renalytix AI plc
RNLX
|
-419.67 | $ 0.21 | 5.66 % | $ 22.7 M | Britain |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 6.32 | -4.03 % | $ 573 M | USA |
 |
Quidel Corporation
QDEL
|
43.3 | $ 21.96 | -19.78 % | $ 925 M | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 211.48 | 0.67 % | $ 38.3 B | USA |
 |
Exagen
XGN
|
-41.6 | $ 10.74 | 3.97 % | $ 190 M | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 14.79 | -10.53 % | $ 795 M | USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 15.74 | -2.69 % | $ 99.4 M | Israel |
|
Biodesix
BDSX
|
-44.15 | $ 8.28 | -3.78 % | $ 1.07 B | USA |
 |
T2 Biosystems
TTOO
|
-143.91 | $ 0.12 | -39.35 % | $ 313 K | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.38 | 2.61 % | $ 958 M | USA |
 |
Guardant Health
GH
|
-29.37 | $ 96.79 | 1.83 % | $ 11.9 B | USA |
 |
Agilent Technologies
A
|
11.3 | $ 147.11 | 0.22 % | $ 44.7 B | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.39 | -0.51 % | $ 11.4 M | USA |